Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/06/24
GRTS ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Gritstone bio, Inc.Accesswire • 03/05/24
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdatesGlobeNewsWire • 03/05/24
Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical TrialGlobeNewsWire • 02/12/24
Gritstone bio Inc. (GRTS) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 10/16/23
Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio's Next Generation COVID-19 VaccineGlobeNewsWire • 10/11/23
Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023GlobeNewsWire • 10/04/23
Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 MillionGlobeNewsWire • 09/27/23
Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdatesGlobeNewsWire • 08/09/23
Gritstone bio Partners with Friends of Cancer Research (Friends) on the ctDNA to Monitor Treatment Response (ctMoniTR) ProjectGlobeNewsWire • 08/07/23
Gritstone bio Announces Publication of Interim Results from Phase 1 Study of Self-amplifying mRNA (samRNA) Vaccine Against COVID-19 in Nature CommunicationsGlobeNewsWire • 06/08/23
Gritstone bio Inc. (GRTS) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/11/23
Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023GlobeNewsWire • 05/03/23
Gritstone bio Inc. (GRTS) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 04/27/23
Gritstone bio Presents 6-month Neutralizing Antibody (nAb) Data at ECCMID 2023 from Two Phase 1 Studies Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 (CORAL)GlobeNewsWire • 04/17/23